Protara Therapeutics TARA
NASDAQ TARA
$2.70 -0.06 (-2.17%)
At close: Oct 2, 2026 · 4:00 PM EDT

Protara Therapeutics (TARA) Net Preferred Shares Issued and Repurchased (2020)

Updated

Protara Therapeutics (TARA) reported Net Preferred Shares Issued and Repurchased of -$40.97 million for Q4 2020.

Analysis

Protara Therapeutics (TARA) Net Preferred Shares Issued and Repurchased (2020) Analysis & Trends

For FY2020, Protara Therapeutics posted Net Preferred Shares Issued and Repurchased of $25.32 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Protara Therapeutics 159.53 Mn 159.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -40.97 Mn
Sep 30, 2020 40.97 Mn
Mar 31, 2020 25.32 Mn
API Access

Protara Therapeutics Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=TARA&period=max&api_key=YOUR_API_KEY